Galt stock price today
WebFind real-time GALT - Galectin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. WebApr 14, 2024 · StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report issued on Thursday. The brokerage issued a …
Galt stock price today
Did you know?
WebApr 10, 2024 · GALT Complete Galectin Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full … WebApr 6, 2024 · finance.yahoo.com - December 13 at 10:10 AM. Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock has dropped to US$2.83, but insiders may have sold too soon at a price of only US$2.17 a share. nasdaq.com - November 18 at 1:55 PM.
Web18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Galectin Therapeutics (GALT) WebSep 21, 2016 · This was followed by algorithm trading taking the stock price lower. There is high open interest on $3, $4, and $5 calls expiring today. The price should reverse and …
WebApr 13, 2024 · The stock has a market capitalization of $121.26 million, a PE ratio of -3.14 and a beta of 1.45. Galectin Therapeutics has a 12 month low of $1.02 and a 12 month … WebApr 5, 2024 · 1 Wall Street analysts have issued 1 year price targets for Galectin Therapeutics' stock. Their GALT share price forecasts range from $11.00 to $11.00. On …
WebFind the latest Galectin Therapeutics Inc. (GALT) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Galectin Therapeutics Inc. (GALT) stock discussion in Yahoo … Discover historical prices for GALT stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Galectin Therapeutics Inc. (GALT), including … Get the detailed quarterly/annual income statement for Galectin Therapeutics Inc. … Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index … Galectin Therapeutics Inc. (GALT) NasdaqCM - NasdaqCM Real Time … View the basic GALT option chain and compare options of Galectin … See Galectin Therapeutics Inc. (GALT) stock analyst estimates, including … See Galectin Therapeutics Inc. (GALT) Environment, Social and Governance … Get the latest Galectin Therapeutics Inc. (GALT) stock news and headlines to …
Web2 days ago · View Galectin Therapeutics Inc GALT investment & stock information. Get the latest Galectin Therapeutics Inc GALT detailed stock quotes, stock data, Real-Time … clipart of rectangleWebGALT Stock Quote. Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield. 1 day 5 days 10 days 1 month 3 months 6 months 1 year. » Buy GALT Online Today! , find the best broker here . clipart of reading to childrenWeb1 day ago · ATLANTA, April 12, 2024 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) today reported preliminary month-end assets under management (AUM) of $1,483.0 billion, an increase of 1.7% versus previous month-end.The firm experienced net long-term inflows of $0.5 billion in the month. Non-management fee earning net inflows were $1.0 billion and … clipart of reading booksWebMar 27, 2024 · Get Galectin Therapeutics Inc (GALT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. bob lee car collectorWebGet the latest Galectin Therapeutics Inc. Common Stock (GALT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... clipart of recyclingWebSep 21, 2016 · This was followed by algorithm trading taking the stock price lower. There is high open interest on $3, $4, and $5 calls expiring today. The price should reverse and move higher with the expiration of these calls, since the opt GALT reported positive results for cancer immunotherapy one week ago. This was followed by algorithm trading taking ... clip art of ravensWebGALT Galectin Therapeutics Inc Galectin Therapeutics Reports Fiscal 2024 Financial Results and Provides Business Update NORCROSS, Ga., March 31, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and... clipart of record albums